What ACA's Uncertain Future Means for Biologics Patents
February 27, 2020
Ted Mathias, Stacie Ropka, PhD, and Rebecca Clegg
Law360
Axinn partners Ted Mathias, Stacie Ropka, and associate Rebecca Clegg authored the Law360 article, "What ACA's Uncertain Future Means for Biologics Patents."
Click here to access the article. A subscription is required.